Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery

Phase 2 Unknown 150 enrolled Luye Pharma Group Ltd.

RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized, double-blind, placebo/positive drug parallel controlled design was used to evaluate the preliminary efficacy and safety of intravenous infusion of LPM3480392 injection using different dosing regimens in subjects with moderate to severe pain after Orthopedic surgery

Timeline

Start: 2024-01-26
Primary completion: 2025-01
Completion: 2025-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	LPM3480392	Unknown	—	Intravenous
Comparator	Morphine	Other / unclassified	—	—

Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery

Summary

Timeline

Drugs

Indications